title: Female sexual disorders: psychiatric aspects.
abstract: OBJECTIVE
  This manuscript reviews the current information concerning female sexual dysfunction that is relevant to general psychiatric practice.
  
  
  METHODS
  Research identified by the key words sexual dysfunction and prevalence, comorbidity, psychiatric drugs, or pharmacotherapy is reviewed.
  
  
  RESULTS
  Epidemiologic studies indicate that approximately 30% of female subjects between ages 18 and 59 years have sexual complaints of at least 3 months' duration in the past year. A high comorbidity with other psychiatric syndromes exists. Many psychiatric drugs are associated with sexual dysfunction. Drug treatments for female sexual dysfunction are being investigated.
  
  
  CONCLUSIONS
  Knowledge concerning the treatment of female sexual dysfunction is important to the general psychiatric clinician.
authors.affiliation: Department of Psychiatry, Case Western Reserve School of Medicine, MetroHealth Medical Center, Cleveland, OH 44109, USA. rsegraves@metrohealth.org
authors.forename: Robert Taylor
authors.initials: RT
authors.lastname: Segraves
mesh_terms: D000928:Antidepressive Agents / Q000008:administration & dosage / Q000627:therapeutic use; D014150:Antipsychotic Agents / Q000009:adverse effects / Q000627:therapeutic use; D015897:Comorbidity; D003430:Cross-Sectional Studies; D005260:Female; D005783:Gender Identity; D006801:Humans; D012735:Sexual Dysfunction, Physiological / Q000139:chemically induced / Q000175:diagnosis / Q000453:epidemiology / Q000523:psychology* / Q000628:therapy
chemical_list: D000928:Antidepressive Agents; D014150:Antipsychotic Agents